🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Thank you to MedUni Wien for awarding me the title of Researcher of the Month this November! It is an honor!

Lukas Hartl presents our study on the effects of #BariatricSurgery at the #LiverMeeting #TLM23 AASLD 🔊 Shearwave Elastography #SWE 🔮 #Steatosis assessment by #CAP 🔪 3 months after surgery ✅pronounced weight loss ⬇️#LSM and #CAP decreased ? Longtterm effects

Disease severity in #ACLD impacts on thyroid hormone homeostasis ⚠️ Lower fT3 is linked to systemic inflammation 🔥 and independently predicts clinical outcomes 🏨📉 Check out the full article in JHEP Reports doi.org/10.1016/j.jhep…

"Von Willebrand factor for outcome prediction within different clinical stages of advanced chronic liver disease" now free to read at bit.ly/49T2dFj #livertwitter

Do not miss our newest publication! Why? 🧐 cACLD and CSPH diagnosed w/o LSM ✨ FIB-4 <1.75 identifies pts with negligible risk for hepatic decompensation 🩸VITRO rules-out/rules-in CSPH in pts with cACLD doi.org/10.1097/HEP.00…

#twitterliver 👋#PortalHypertension Fans !! Meet the apsiring members 👩‍🔬🧑‍🔬👨‍⚕️👩‍⚕️ of the clinical research group MOTION divided in 8 work packages assigned to their unique expertise...… ⬇️Follow for more insights…⬇️

#LiverTwitter 3 Relay Teams of the Vienna Liver News have finished 🥇🥈🥉 Vienna City Marathon #VCM2024 🏃🏻🏃🏻‍♂️ for #Liver #Disease Awareness

What is “NICER” than “Anticipate”? data on spleen stiffness in predicting CSPH Mattias Mandorfer The Baveno Cooperation: an EASL Consortium EASLnews #EASLCongress

Vienna Liver News 2024 EASLnews congress #Liver #Fibrosis #PortalHypertension #LiverStiffness #Spleenstiffness #Decompensation #TIPS #ViralHepatitis we already look forward to #EASLcongress 2025 in #Amsterdam

Advanced #liverdisease is the second most common cause of lost working years. A #MedUniVienna team has identified a threshold for a simple blood test that can identify people at increased risk of complications without special testing. ➡️ bit.ly/3VZjTuc Journal of Hepatology

Easy access to healthcare are essential for the elimination of #HCV on a global scale. Check out out article on an HCV hotline, which helped to treat patients during the #COVID pandemic. Wiley doi: 10.1111/jvh.13746 #topdownloadedArticle

Humbled to have completed my PhD today. This is the result of 4 years of work under exceptional supervision by Thomas Reiberger 🥳

TIPS implantation not only leads to ⬇️ of portal pressure, but also ⬇️ systemic inflammation 🔥🧯 ⬇️ bacterial translocation 🦠 😃 IL-6 decrease independently linked to improved outcomes Fresh off the press: doi.org/10.1016/j.jhep…

#twitterliver #PortalHypertension WP1 focuses on the classical & alternative renin-angiotensin system as a disease-driving mechanism in patients with compensated advanced chronic liver disease & investigates potentially beneficial effects of telmisartan in this patient group.⬇️⬇️

🆕 Identification of optimal portal pressure decrease to control #ascites while minimizing HE after #TIPS: A multicenter study 💡60-80% PPG reduction = reduced ascites w/o increased oHE risk! 👥 M. Kabelitz et al in Hepatology 🔗bit.ly/4fYNIlE #livertwitter #liverx

🧬 New Study Alert! 🧬 Groundbreaking research by Thomas Reiberger, Lukas Hartl & colleagues reveals that decreasing IL-6 levels after #TIPS implantation can predict better outcomes in decompensated cirrhosis. #LiverHealth #Cirrhosis #MedicalResearch #TIPS #inflammation

Vienna Liver News MedUni Wien EASLnews Congress #2025 in #Amsterdam

The authors of today’s #readoftheweek📚 explore how TIPS leads to a sustained reduction of SI and bacterial translocation in patients with decompensated cirrhosis. Read here this JHEP Reports article: jhep-reports.eu/article/S2589-… 🙏Lukas Hartl Anja Tiede Nina Dominik

📈Activation #Vasopressin in #Cirrhosis tries to compensate🫀#hemodynamic &#sodium #fluid abnormalities Drs. HARTL & HINTERSTEININGER of MedUni Wien in🤝w/ efclif.com show in📕CGH 🔗 t.ly/joCs5 ▶️#Vasopressin biomarker #COPEPTIN predicts #ACLF

The authors in today’s #readoftheweek📚 evaluated the prognostic relevance of residual ascites grades in patients with advanced chronic liver disease after #TIPS placement. Read here this JHEP Reports article: jhep-reports.eu/article/S2589-… 🙏 Lukas Hartl, Mathias Jachs, Anja Tiede,